A Study on Rheumatoid Arthritis Patients Treated With Rituximab

Roche

Status: Completed

Conditions: Rheumatoid Arthritis

Treatments: Drug: Rituximab

Study type: Observational

Funder types: Industry

Identifiers

NCT02622503

ML30146

Details and patient eligibility

About

The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.

Enrollment: 81 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Rheumatoid arthritis (RA) patients treated with rituximab in Finland

Exclusion criteria

• Not applicable

Trial design

81 participants in 1 patient group

Patients with rheumatoid arthritis

Description:

Patients with rheumatoid arthritis receiving rituximab will be observed for treatment responses.

Treatment:

Drug: Rituximab